Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-02-22 Sale | 2022-02-24 8:22 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 84,515 | $19.56 | $1,653,113 | 1,220,036 (Direct) | View |
| 2021-05-11 Sale | 2021-05-13 8:32 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 20,770 | $24.98 | $518,794 | 1,288,127 (Direct) | View |
| 2020-05-08 Sale | 2020-05-08 9:18 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 45,000 | $25.84 | $1,162,800 | 1,052,568 (Direct) | View |
| 2019-05-07 Purchase | 2019-05-08 5:13 pm | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 370,370 | $1.08 | $400,000 | 1,560,242 (Direct) | View |
| 2019-02-21 Sale | 2019-02-22 7:35 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 26,250 | $21.25 | $557,813 | 1,042,251 (Direct) | View |
| 2018-12-28 Purchase | 2019-01-02 4:12 pm | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 50,000 | $1.0914 | $54,570 | 835,073 (Direct) | View |
| 2018-12-26 Purchase | 2018-12-28 4:21 pm | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 116,401 | $0.97368 | $113,338 | 785,073 (Direct) | View |
| 2018-11-15 Purchase | 2018-11-19 4:03 pm | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 500,000 | $1.3611 | $680,550 | 668,672 (Direct) | View |
| 2018-05-07 Sale | 2018-05-07 8:07 pm | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $22.15 | $332,250 | 1,034,314 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-06-15 Option Award | 2022-06-17 5:13 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 2,255 | $0 | 38,301 (Direct) | View |
| 2022-06-09 Option Award | 2022-06-10 4:18 pm | N/A 2032-06-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-05-26 Option Award | 2022-05-27 9:19 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 19,575 | $0 | 1,239,611 (Direct) | View |
| 2021-11-30 Option Award | 2021-12-01 4:12 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 2,222,222 | $0.36 | 5,061,929 (Direct) | View |
| 2021-07-01 Option Award | 2021-07-02 5:27 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,275 | $0 | 36,046 (Direct) | View |
| 2021-06-14 Option Award | 2021-06-15 4:43 pm | N/A 2031-06-13 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2021-05-27 Option Award | 2021-05-28 8:26 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 16,424 | $0 | 1,304,551 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | 2016-05-26 2023-05-25 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,000 | $0 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $3.13 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $3.38 | 1,288,127 (Direct) | View |
| 2021-05-11 Exercise | 2021-05-13 8:32 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 40,000 | $6.3 | 1,288,127 (Direct) | View |
| 2020-12-04 Option Award(A) | 2021-01-27 8:16 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 2,839,707 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:21 pm | 2020-12-04 2025-12-04 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 595,146 | $0.125 | 2,581,875 (Direct) | View |
| 2020-12-04 Option Award | 2020-12-07 4:21 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 793,528 | $0.6301 | 2,581,875 (Direct) | View |
| 2020-11-24 Other | 2020-11-27 4:05 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 255,094 | $0 | 2,875,000 (Indirect) | View |
Ownership | 2020-10-23 1:23 pm | N/A N/A | Eucrates Biomedical Acquisition Corp. | EUCR | PAPADOPOULOS STELIOS Director 10% Owner | 0 | $0 | 2,875,000 (Indirect) | View |
| 2020-06-17 Option Award | 2020-06-19 4:40 pm | N/A 2030-06-16 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 23,250 | $0 | 23,250 (Direct) | View |
| 2020-06-03 Option Award | 2020-06-05 5:20 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,470 | $0 | 34,771 (Direct) | View |
| 2020-05-21 Option Award | 2020-05-22 9:05 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,538 | $0 | 1,188,897 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 8:18 pm | 2013-12-06 2020-12-05 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,791 | $0 | 1,173,359 (Direct) | View |
| 2020-05-13 Exercise | 2020-05-15 8:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 120,791 | $5.82 | 1,173,359 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | 2013-05-23 2020-05-22 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 45,000 | $0 | 1,052,568 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 30,000 | $4.58 | 1,052,568 (Direct) | View |
| 2020-05-08 Exercise | 2020-05-08 9:18 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $5.92 | 1,052,568 (Direct) | View |
| 2020-02-03 Conversion | 2020-02-04 4:59 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 930,952 | $0 | 2,039,521 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-26 08:56 am | 2019-12-24 2024-12-24 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 846,320 | $0.125 | 930,952 (Direct) | View |
| 2019-12-24 Option Award | 2019-12-26 08:56 am | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 84,632 | $6.66 | 930,952 (Direct) | View |
| 2019-10-10 Option Award | 2019-10-15 4:45 pm | N/A 2029-10-09 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 46,500 | $0 | 46,500 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-20 5:54 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,905 | $0 | 33,301 (Direct) | View |
| 2019-05-23 Option Award | 2019-05-24 8:43 pm | 2019-05-23 2026-05-22 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 30,951 | $0 | 1,073,202 (Direct) | View |
| 2019-05-07 Option Award(A) | 2019-05-21 4:46 pm | 2019-05-07 2024-05-07 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 370,370 | $0.125 | 1,560,242 (Direct) | View |
| 2019-05-07 Option Award(A) | 2019-05-21 4:46 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 370,370 | $1.08 | 1,560,242 (Direct) | View |
| 2019-02-21 Exercise | 2019-02-22 7:35 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 11,250 | $4.16 | 1,042,251 (Direct) | View |
| 2019-02-21 Exercise | 2019-02-22 7:35 pm | 2009-05-14 2019-05-13 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 26,250 | $0 | 1,042,251 (Direct) | View |
| 2019-02-21 Exercise | 2019-02-22 7:35 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $4.57 | 1,042,251 (Direct) | View |
| 2018-11-12 Option Award | 2018-11-21 5:29 pm | N/A N/A | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 20,910 | $0 | 168,672 (Direct) | View |
| 2018-11-12 Disposition | 2018-11-21 5:29 pm | N/A 2022-02-08 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 20,910 | $0 | 168,672 (Direct) | View |
| 2018-06-12 Option Award | 2018-06-14 5:27 pm | N/A N/A | BIOGEN INC. | BIIB | PAPADOPOULOS STELIOS Director | 1,450 | $0 | 31,396 (Direct) | View |
| 2018-06-01 Option Award | 2018-06-05 4:29 pm | N/A 2028-05-31 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 55,000 | $0 | 55,000 (Direct) | View |
| 2018-05-24 Option Award | 2018-05-24 8:28 pm | 2018-05-24 2025-05-23 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 23,811 | $0 | 1,058,125 (Direct) | View |
| 2018-05-17 Option Award | 2018-05-21 4:41 pm | N/A 2028-05-16 | Regulus Therapeutics Inc. | RGLS | PAPADOPOULOS STELIOS Director | 75,000 | $0 | 75,000 (Direct) | View |
| 2018-05-07 Exercise | 2018-05-07 8:07 pm | 2011-05-19 2018-05-18 | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $0 | 1,034,314 (Direct) | View |
| 2018-05-07 Exercise | 2018-05-07 8:07 pm | N/A N/A | EXELIXIS INC. | EXEL | PAPADOPOULOS STELIOS Director | 15,000 | $11.66 | 1,034,314 (Direct) | View |